Enzyme Modulators
Enzyme modulators are compounds that can enhance or inhibit the activity of enzymes, thereby regulating the rate of biochemical reactions. These modulators play a critical role in controlling metabolic pathways, cell signaling, and various physiological processes. Enzyme modulators are widely used in research and drug development to study enzyme functions and to develop therapeutic agents. At CymitQuimica, we offer a comprehensive range of high-quality enzyme modulators to support your research in enzyme regulation and drug discovery.
Subcategories of "Enzyme Modulators"
Found 693 products of "Enzyme Modulators"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Gabexate mesylate
CAS:Serine protease inhibitorFormula:C17H27N3O7SPurity:Min. 95%Molecular weight:417.15697Ro492097
CAS:Inhibitor of γ-secretase and Notch signallingFormula:C22H20F5N3O3Purity:Min. 95%Molecular weight:469.4 g/molZofenopril calcium
CAS:Angiotensin-converting enzyme inhibitor; antioxidantFormula:C44H46N2O8S4•CaPurity:Min. 95%Color and Shape:PowderMolecular weight:899.17 g/molTiludronic acid disodium
CAS:Farnesyltransferase inhibitorFormula:C7H9ClO6P2S•Na2Purity:Min. 95%Color and Shape:PowderMolecular weight:364.59 g/molNVP-TAE684
CAS:Inhibitor of NPM-ALK kinaseFormula:C30H40ClN7O3SPurity:Min. 95%Molecular weight:614.2 g/molGinkgolic acid (C13:0)
CAS:Sumoylation inhibitor; reported to inhibit histone acetylation transferaseFormula:C20H32O3Purity:Min. 95%Color and Shape:White PowderMolecular weight:320.47 g/molMG 132
CAS:MG 132 is a modified tripeptide that acts as proteasomal inhibitor. In 2006, MG 132 has been experimentally tested in in vitro cell-based and in vivo models for to assess its use in the medical treatment of Parkinson's disease.Formula:C26H41N3O5Purity:Min. 95%Color and Shape:PowderMolecular weight:475.30462SU 3327
CAS:SU 3327, originally introduced as a thiadiazole JNK inhibitor (De et al. 2009) has recently been identified as having antibiotic activity against a broad range of bacteria including drug-resistant gram positive and negative strains (Strokes et al. 2020). This molecule has been given the fictional name ‘Halicin’ inspired by the AI approach used to discover its novel biological activity.Formula:C5H3N5O2S3Purity:Min. 95%Color and Shape:PowderMolecular weight:261.31 g/molRapamycin-13C,d3 (contains d0) - Technical Grade
CAS:Controlled ProductBinds to FK506 binding proteins (FKBPs) to form a complex that inhibits mammalian targets of rapamycin (mTOR). Blocks p70 S6 kinase activation by interleukin-2 and thereby inhibits proliferation of T cells. Induces differentiation of human pluripotent stem cells (hPSCs) to mesendoderm and blood progenitor cells.Formula:C50CH76D3NO13Purity:Min. 95%Molecular weight:918.18 g/molSurfen
CAS:Small molecule antagonist of heparan sulfate that binds to glycosaminoglycans electrostatically. Surfen neutralised anti-coagulant activity of unfractionated and low molecular weight heparins, inhibited enzymatic sulfation and degradation reactions. Surfen also blocked signalling and cell adhesion to fibronectin that was triggered by heparan sulphate.Formula:C21H22Cl2N6OPurity:Min. 95%Molecular weight:445.34 g/molZanubrutinib
CAS:Inhibitor of Bruton's tyrosine kinase (BTK)Formula:C27H29N5O3Purity:Min. 95%Molecular weight:471.55 g/molYM 60828
CAS:Inhibits factor Xa; anti-thrombotic
Formula:C27H33Cl2N5O5SPurity:Min. 95%Molecular weight:610.55 g/molSpirapril hydrochloride
CAS:Spirapril hydrochloride is an antihypertensive agent, which is a synthetic pharmaceutical compound designed to treat high blood pressure. The compound is derived from laboratory synthesis aimed at modulating the renin-angiotensin-aldosterone system. Its mode of action involves the inhibition of angiotensin-converting enzyme (ACE), which is crucial for the conversion of angiotensin I to the vasoconstrictor peptide angiotensin II. Angiotensin II is responsible for the constriction of blood vessels and an increase in blood pressure. By inhibiting this enzyme, Spirapril hydrochloride effectively reduces vascular resistance and lowers blood pressure.Formula:C22H30N2O5S2•HClPurity:Min. 95%Molecular weight:503.08 g/molSorafenib
CAS:Sorafenib is a drug that belongs to the class of multikinase inhibitors. It inhibits a number of kinases, including the Mcl-1 protein, which is involved in apoptosis along with blocking picolinic acid (PA), an endogenous metabolite involved in apoptosis signal transduction. Sorafenib also binds to epidermal growth factor receptor (EGFR) on the surface of cancer cells, inhibiting the production of proteins that are required for angiogenesis, thus blocking the formation of new blood vessels. Sorafenib may also inhibit P-glycoprotein (Pgp) activity. Overall, these cytotoxic effects give Sorafenib anti-tumor properties, inhibiting angiogenesis and cellular transformation, which are the two main processes of tumor growth and metastasis. Sorafenib has been shown to be effective against a range of solid tumors such as breast, prostate and lung cancers and is also used for the treatment of metastatic colorectal cancer and renal cell carcinoma. A combination therapy group found that sorafenib was more effective when used with interferon alfa-2b for the treatment of advanced renal cell carcinoma. Sorafenib also has the potential for drug interactions with other drugs that are metabolized by cytochrome P450 enzymes.
Formula:C21H16ClF3N4O3Purity:Min. 98.0 Area-%Color and Shape:White PowderMolecular weight:464.82 g/molSB 505124
CAS:Inhibitor of ALK4, ALK5, and ALK7 receptorsFormula:C20H21N3O2Purity:Min. 95%Molecular weight:335.4 g/molForetinib
CAS:Inhibits MET, VEGFR2, Ron, AXL, Tie-2, Flt-1, Flt-3 and Flt-4 tyrosine kinases
Formula:C34H34F2N4O6Purity:Min. 95%Color and Shape:White To Off-White SolidMolecular weight:632.24464Regorafenib monohydrate
CAS:Multi-kinase inhibitor; inhibits epoxide hydrolase; antineoplasticFormula:C21H15ClF4N4O3•H2OPurity:Min. 95%Molecular weight:500.83 g/molMLN 0905
CAS:Inhibitor of Polo-like kinase 1Formula:C24H25F3N6SPurity:Min. 95%Molecular weight:486.56 g/molErlotinib base
CAS:Tyrosine kinase inhibitor; affects EGFR receptor; pancreatic cancer treatmentFormula:C22H23N3O4Purity:Min. 99 Area-%Color and Shape:PowderMolecular weight:393.44 g/molIWP-2
CAS:Antagonist of Wnt signalling pathway by inhibiting the activity of Porcn, a member of the membrane-bound O-acyltransferase (MBOAT) family. Porcn is required for the palmitoylation of Wnt, mediating its secretion and signalling. Inhibits self-renewal in embryonic stem cells, whilst promoting differentiation to epiblast stem cells.Formula:C22H18N4O2S3Purity:Min. 95%Color and Shape:White To Off-White SolidMolecular weight:466.05919
